Joel Habener: Difference between revisions
Content deleted Content added
categories |
rmoved {{uncategorised|date=June 2020}} |
||
| Line 4: | Line 4: | ||
{{reflist}} |
{{reflist}} |
||
{{uncategorised|date=June 2020}} |
|||
[[Category:Harvard Medical School staff]] |
[[Category:Harvard Medical School staff]] |
||
[[Category:Medical researchers]] |
[[Category:Medical researchers]] |
||
Revision as of 17:23, 25 June 2020
Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2]